The mRNA technology behind coronavirus vaccines is now being used to create bespoke vaccines for cancer patients.

Another recent federal study, published in the journal JAMA Pediatrics in February, showed approximately 1.01 million ...

The UK has become the first country in the world to authorise an updated COVID-19 booster vaccine directed at the Omicron variant, giving a green light to Moderna's mRNA-1273.214 shot.

The bivalent vaccine is designed to defend against BA.1, an Omicron subvariant, and an early strain of the novel coronavirus. Pfizer Inc. and Moderna Inc. have been developing their versions of ...

Now that Novavax has been added to the revamped COVID vaccines, you'll want to make sure to check on the changes to cost and ...

The rivalry between Moderna and Pfizer/BioNTech in commercialising their COVID-19 vaccines has now spilled ... shots targeting new variants like Omicron as COVID-19 becomes endemic.

It has been five years since the World Health Organisation (WHO) declared COVID-19 a pandemic in March 2020 a decision that ...

Five years ago on Tuesday, the World Health Organization declared COVID-19 a global pandemic, and the impact of the virus and ...

The current COVID-19 vaccine is 33% effective at preventing emergency department or urgent care visits among adults of all ages. It also is 45% to 46% effective at preventing hospitalizations in older ...

The large inflow of cash from Comirnaty gross profits in 2021-22 has further secured BioNTech's financial health. Outside of BioNTech’s covid-19 vaccine candidates, we think the earliest approval ...